5/17/2016
Celimmune and Celiac Disease Foundation Partner for Phase 2 Clinical Drug Study
Celimmune, in partnership with the University of Chicago Celiac Disease Center, and Celiac Disease Foundation have joined forces to deploy the iCureCeliac patient registry as a screen for phase 2 clinical study for refractory celiac disease type II. This is the first-ever use of the new and growing iCureCeliac registry to support celiac disease therapeutic treatment…
Continue Reading
